About Maxirich
Maxirich is a Healthcare company based in India founded in 2019. Nutritional supplements including multivitamins, omega 3 capsules, and tonics for health support. The company has 363 employees. Its Indian entity Cipla Health Limited reported revenue of ₹1,229 Cr. Maxirich offers products and services including Maxirich Gold and Maxirich Omega 3. Its focus areas include Nutraceuticals, Dietary Supplements, Vitamins and Minerals and Wellness.
Company details
Maxirich supplements are developed by Cipla Health Ltd to address gaps in daily nutrient intake, offering products like multivitamins and omega 3 capsules that incorporate vitamins, minerals, and herbal extracts such as ginseng. These are designed to enhance immunity, energy levels, and cognitive function, with a focus on gluten-free and vegetarian options. Over 15 years of consumer trust is reflected in the range, which aims to complement regular diets by providing essential nutrients to promote well-being without overstatement.
- Headquarters India
- Employees 363
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website maxirich.com
- Social Facebook Instagram
- Legal Name Cipla Health Ltd
- Date of Incorporation 27 Aug, 2015
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1,229 Cr
FY 2025 · +17% YoY
- Net Profit₹119 Cr
FY 2025 · 10% margin
- EBITDA₹186 Cr
FY 2025 · 15% margin
- Employee Count363
Associated legal entities of Maxirich
Maxirich operates through Cipla Health Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cipla Health Limited CIN U24100MH2015PLC267880 | Active | 27 Aug 2015 | Mumbai, Maharashtra | ₹1,229 Cr | 363 | 9 | View details |
Products & Services of Maxirich
Maxirich offers a comprehensive portfolio of products and services, including Maxirich Gold and Maxirich Omega 3.
Multivitamin softgels are formulated with ginseng extract and essential vitamins to support energy utilization and immune function.
Omega 3 capsules are developed with EPA and DHA to aid heart, eye, and brain health through improved nutrient absorption.
Board of directors of Cipla Health Limited (Maxirich)
Cipla Health Limited is the primary company behind Maxirich. The board of Cipla Health Limited currently have 6 directors; the longest-serving is Chandrashekhar Ramachandran Iyer, appointed in 2019. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chandrashekhar Ramachandran Iyer DIN 07173310 | Director | 27 Mar 2019 | 7 yrs 7 mo | Cipla Health Limited |
| Amrita Nautiyal DIN 00123512 | Director | 27 Mar 2019 | 7 yrs 7 mo | Cipla Health Limited |
| Achin Gupta DIN 09491674 | Director | 15 Feb 2022 | 4 yrs 8 mo | Cipla Health Limited |
| Shivam Puri DIN 09552961 | Managing Director | 01 Apr 2022 | 4 yrs 7 mo | Cipla Health Limited |
| Umang Vohra DIN 02296740 | Director | 29 Nov 2022 | 3 yrs 11 mo | Cipla Health Limited |
| Geena Malhotra DIN 03134169 | Director | 08 May 2024 | 2 yrs 5 mo | Cipla Health Limited |
Financials of Maxirich
Figures of Cipla Health Limited, the primary company behind Maxirich, for FY 2025. Revenue was ₹1,229 Cr (+17% year on year). Net profit was ₹119 Cr (10% margin). EBITDA was ₹186 Cr (15% margin). Revenue has grown at a compounded annual rate of +33% over three years and +43% over five years.
- ₹1,229 CrRevenue · FY 2025 · +17% YoY
- ₹119 CrNet profit · 10% margin
- ₹186 CrEBITDA · 15% margin
- ₹2.33 CrPaid-up capital
- 363Employees (provident fund records)
- +33%Revenue CAGR, 3 years
- +43%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cipla Health Limited are on its company page.
Detailed financial statements for Maxirich
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Maxirich
The website of Maxirich (maxirich.com) receives about 4.5K visits a month.
- Monthly visits4.5K
▼ 33.9% vs previous month
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Maxirich (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Maxirich
Complete news archive for Maxirich
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxirich
Maxirich was founded in 2019.
Maxirich is headquartered in India.
Maxirich has 363 employees.
The primary company behind Maxirich, Cipla Health Limited, reported revenue of ₹1,229 Cr for FY 2025, up 17% year on year.
Maxirich supplements are developed by Cipla Health Ltd to address gaps in daily nutrient intake, offering products like multivitamins and omega 3 capsules that incorporate vitamins, minerals, and herbal extracts such as ginseng. These are designed to enhance immunity, energy levels, and cognitive function, with a focus on gluten-free and vegetarian options. Over 15 years of consumer trust is reflected in the range, which aims to complement regular diets by providing essential nutrients to promote well-being without overstatement.
Maxirich offers Maxirich Gold and Maxirich Omega 3.
Maxirich operates through Cipla Health Limited.
The legal entities of Maxirich currently have 8 directors, including Siddharth Rajesh Jain, Geena Malhotra, Umang Vohra and others.